Albemarle Corp Stock

Albemarle Corporation (ALB) — FY2025 Annual Report

Albemarle appears to remain under significant pressure from the lithium down-cycle, though the FY2025 figures suggest the worst may be moderating. The company reported roughly $5.14 billion in revenue against a net loss of about $511 million, marking a second consecutive annual loss but one considerably narrower than 2024's roughly $1.18 billion deficit. The trajectory seems to be one of stabilization rather than recovery, with revenue still down sharply from the 2023 peak near $9.6 billion.

The most striking feature of the income statement is the dramatic swing in gross margin, which appears to have rebounded from a barely-positive 1.2% in 2024 to roughly 13% in 2025. This recovery may reflect the earlier restructuring efforts working through the cost base, as 2024 had been burdened by more than $1.1 billion in restructuring charges and asset write-offs that did not recur at the same scale. That said, the operating line remained negative, dragged down by a $181 million goodwill impairment tied to the Ketjen segment and $246 million in long-lived asset impairments related to the Refining Solutions business. The steep decline in equity income from unconsolidated investments—falling to about $244 million from $715 million—could indicate that the Windfield joint venture, historically a major earnings contributor, is feeling the same pricing pressure as the consolidated business.